La Jolla Pharmaceutical Company
LJPC
LJPC was delisted on the 19th of August, 2022.
53 hedge funds and large institutions have $266M invested in La Jolla Pharmaceutical Company in 2015 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 22 increasing their positions, 6 reducing their positions, and 8 closing their positions.
267% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 6
163% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 8
128% more call options, than puts
Call options by funds: $2.24M | Put options by funds: $981K
44% more capital invested
Capital invested by funds: $184M → $266M (+$81.9M)
33% more funds holding
Funds holding: 40 → 53 (+13)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$10.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.86M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.62M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
+$3.1M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$16.1M |
| 2 |
BGA
Belmont Global Advisors
Dallas,
Texas
|
-$2.51M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$1.77M |
| 4 |
D.E. Shaw & Co
New York
|
-$1.49M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.4M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WA
51
WFG Advisors
Dallas,
Texas
| $3K | -$10.3K | -500 | -81% |
|
52
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $185 | +$156K | +7,566 | New |
|
|
EI
53
EAM Investors
Solana Beach,
California
| – | -$1.77M | -97,003 | Closed |
|
|
54
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$1.4M | -67,953 | Closed |
|
|
ARTA
55
A.R.T. Advisors
New York
| – | -$357K | -19,557 | Closed |
|
56
Goldman Sachs
New York
| – | -$294K | -16,052 | Closed |
|
|
TMC
57
Trellus Management Company
Delray Beach,
Florida
| – | -$224K | -12,252 | Closed |
|
|
VKH
58
Virtu KCG Holdings
New York
| – | -$201K | -10,957 | Closed |
|
59
Simplex Trading
Chicago,
Illinois
| – | -$29.1K | -1,413 | Closed |
|
|
BAM
60
Brave Asset Management
Summit,
New Jersey
| – | -$11K | -600 | Closed |
|
|
BRWM
61
B. Riley Wealth Management
Memphis,
Tennessee
| – | +$783 | +38 | New |
|
LJPC Hedge Fund Activity: Q2 2015 in Review
53 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical Company (LJPC) for Q2 2015, worth a combined $266M — up 44% from $184M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new LJPC positions and 8 closed out — a net gain of 13 holders — while 22 added to existing stakes and 6 trimmed.
The largest buyer was Tang Capital Management, adding an estimated $10.7M. The largest seller was RTW Investments, cutting an estimated $16.1M.
- 53 institutional investors held La Jolla Pharmaceutical Company (LJPC) as of Q2 2015, up from 40 in Q1 2015.
- Funds reported $266M of La Jolla Pharmaceutical Company stock for Q2 2015, up 44% quarter-over-quarter.
- 21 funds opened new La Jolla Pharmaceutical Company positions in Q2 2015 and 8 closed out, a net change of +13 holders.
- The largest La Jolla Pharmaceutical Company buyer in Q2 2015 was Tang Capital Management, an estimated $10.7M added.
- The largest La Jolla Pharmaceutical Company seller in Q2 2015 was RTW Investments, an estimated $16.1M sold.
Based on aggregated 13F filings for Q2 2015.